CTLA-4 Blockade Plus Adoptive T-Cell Transfer Promotes Optimal Melanoma Immunity in Mice
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0000000000000064
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)